{"id":"https://openalex.org/W4400444615","doi":"https://doi.org/10.1016/j.eururo.2024.06.022","title":"Re: Thomas Powles, Bego\u00f1a P\u00e9rez-Valderrama, Shilpa Gupta, et al. Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer. N Engl J Med 2024;390:875\u201388","display_name":"Re: Thomas Powles, Bego\u00f1a P\u00e9rez-Valderrama, Shilpa Gupta, et al. Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer. N Engl J Med 2024;390:875\u201388","publication_year":2024,"publication_date":"2024-07-09","ids":{"openalex":"https://openalex.org/W4400444615","doi":"https://doi.org/10.1016/j.eururo.2024.06.022","pmid":"https://pubmed.ncbi.nlm.nih.gov/38987086"},"language":"en","primary_location":{"id":"doi:10.1016/j.eururo.2024.06.022","doi":"https://doi.org/10.1016/j.eururo.2024.06.022","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.eururo.2024.06.022","pdf_url":null,"source":{"id":"https://openalex.org/S96871409","display_name":"European Urology","issn_l":"0302-2838","issn":["0302-2838","1421-993X","1873-7560"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Urology","raw_type":"journal-article"},"volume":null,"type":"letter","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038614419","display_name":"Enrique Grande","orcid":"https://orcid.org/0000-0002-0134-4732","observed_orcids":["https://orcid.org/0000-0002-0134-4732"]},"institutions":[{"id":"https://openalex.org/I232005693","display_name":"Universidad Francisco de Vitoria","ror":"https://ror.org/03ha64j07","country_code":"ES","type":"education","lineage":["https://openalex.org/I232005693"]},{"id":"https://openalex.org/I4210158781","display_name":"MD Anderson Cancer Center Madrid","ror":"https://ror.org/05mq65528","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210158781"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Enrique Grande","raw_affiliation_strings":["Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain; Facultad de Medicina, Universidad Francisco de Vitoria, Madrid, Spain. Electronic address: egrande@oncomadrid.com","Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain","Facultad de Medicina, Universidad Francisco de Vitoria, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain; Facultad de Medicina, Universidad Francisco de Vitoria, Madrid, Spain. Electronic address: egrande@oncomadrid.com","institution_ids":["https://openalex.org/I232005693","https://openalex.org/I4210158781"]},{"raw_affiliation_string":"Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain","institution_ids":["https://openalex.org/I4210158781"]},{"raw_affiliation_string":"Facultad de Medicina, Universidad Francisco de Vitoria, Madrid, Spain","institution_ids":["https://openalex.org/I232005693"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079820994","display_name":"Alison Jane Birtle","orcid":"https://orcid.org/0000-0002-2621-0909","observed_orcids":["https://orcid.org/0000-0002-2621-0909"]},"institutions":[{"id":"https://openalex.org/I1293129422","display_name":"Lancashire Teaching Hospitals NHS Foundation Trust","ror":"https://ror.org/02j7n9748","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1293129422"]},{"id":"https://openalex.org/I185852735","display_name":"University of Lancashire","ror":"https://ror.org/010jbqd54","country_code":"GB","type":"education","lineage":["https://openalex.org/I185852735"]},{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alison Jane Birtle","raw_affiliation_strings":["Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK; University of Manchester, Manchester, UK; University of Central Lancashire, Preston, UK","Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK","University of Central Lancashire, Preston, UK","University of Manchester, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK; University of Manchester, Manchester, UK; University of Central Lancashire, Preston, UK","institution_ids":["https://openalex.org/I1293129422","https://openalex.org/I185852735","https://openalex.org/I28407311"]},{"raw_affiliation_string":"Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK","institution_ids":["https://openalex.org/I1293129422"]},{"raw_affiliation_string":"University of Central Lancashire, Preston, UK","institution_ids":["https://openalex.org/I185852735"]},{"raw_affiliation_string":"University of Manchester, Manchester, UK","institution_ids":["https://openalex.org/I28407311"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034005227","display_name":"Ashish M. Kamat","orcid":"https://orcid.org/0000-0003-3546-9928","observed_orcids":["https://orcid.org/0000-0003-3546-9928"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ashish M. Kamat","raw_affiliation_strings":["Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5038614419"],"corresponding_institution_ids":["https://openalex.org/I232005693","https://openalex.org/I4210158781"],"apc_list":{"value":5250,"currency":"USD","value_usd":5250},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":18,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"86","issue":"6","first_page":"e152","last_page":"e153"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/enfortumab-vedotin","display_name":"enfortumab vedotin","score":0.9959999918937683},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":1.0},{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.8059999942779541},{"id":"https://openalex.org/keywords/advanced-bladder-cancer","display_name":"advanced bladder cancer","score":0.6399999856948853},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.6549999713897705},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.5189999938011169}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9368318319320679},{"id":"https://openalex.org/C3020745361","wikidata":"https://www.wikidata.org/wiki/Q2501186","display_name":"Urothelial cancer","level":4,"score":0.8689190149307251},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.7069399952888489},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5049231648445129},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4713563323020935},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43093788623809814},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.1955733597278595},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.12071001529693604}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1016/j.eururo.2024.06.022","doi":"https://doi.org/10.1016/j.eururo.2024.06.022","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.eururo.2024.06.022","pdf_url":null,"source":{"id":"https://openalex.org/S96871409","display_name":"European Urology","issn_l":"0302-2838","issn":["0302-2838","1421-993X","1873-7560"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Urology","raw_type":"journal-article"},{"id":"pmid:38987086","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38987086","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European urology","raw_type":"Letter"},{"id":"pmh:oai:clok.uclan.ac.uk:52369","doi":null,"is_oa":false,"landing_page_url":"https://clok.uclan.ac.uk/52369/","pdf_url":null,"source":{"id":"https://openalex.org/S4306402361","display_name":"CLOK (University of Central Lancashire)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I185852735","host_organization_name":"University of Lancashire","host_organization_lineage":["https://openalex.org/I185852735"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Other"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":5,"referenced_works":["https://openalex.org/W2152762320","https://openalex.org/W3087464965","https://openalex.org/W4387859553","https://openalex.org/W4392498919","https://openalex.org/W4392769651"],"related_works":["https://openalex.org/W4394595366","https://openalex.org/W3163073257","https://openalex.org/W4392982527","https://openalex.org/W3159920199","https://openalex.org/W7221808738","https://openalex.org/W4401743023","https://openalex.org/W4247922271","https://openalex.org/W2988589394","https://openalex.org/W3135576779","https://openalex.org/W4200360405"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":5}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2024-07-10T00:00:00"}